Clinical Trial Update: CorONa Virus edoxabaN ColchicinE (CONVINCE) COVID-19 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for CONVINCE evaluating edoxaban and colchicine for COVID-19, currently terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars-cov Infection

Drugs mentioned

• COLCHICINE (Colchicine)
• Edoxaban (edoxaban)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: SARS-CoV Infection, COVID-19 | Phase 3 | Status: TERMINATED